Cajal Neuroscience

www.cajalneuro.com
1616 Eastlake Ave E, Suite 300
Seattle, WA 98102

Company Info

Year Established
2020

Contacts

Ignacio Munoz-Sanjuan, PhD
CEO

Ian Peikon, PhD
Co-Founder & CSO

Kimberly Scearce-Levie, PhD
CDO

Leslie Aberman, JD
General Counsel

Valerie Huang, MBA
Strategy & Corporate Development

Company Description

Cajal Neuroscience is a drug discovery company that focuses on neurodegenerative disease. The company develops drugs for neurodegenerative disease.